European Medicines Agency’s Committee for Medicinal Products for Human Use issues positive opinion on marketing authorisation application for FAMPYRA
20 May 2011 | By Biogen Idec
Biogen Idec announced that FAMPYRA(R) (prolonged-release fampridine tablets) has been granted a positive opinion for conditional approval from the EMA's CHMP...